A team of researchers based in France has examined the consequences of microwave and electron-beam treatments on food and its packaging using high performance liquid chromatography (HPLC) and gas chromatography (GC)
Photo Credit: Studio 504/Getty Images
A team of researchers based in France has examined the consequences of microwave and electron-beam treatments on food and its packaging using high performance liquid chromatography (HPLC) and gas chromatography (GC).1
The packaging of the food we eat poses a huge challenge to the food industry. Consumer demands place extra emphasis on the type of packaging that is produced. It should be compact, microwavable, recyclable, not to mention biodegradable. It must also preserve the food contained within. As a result, manufacturers are turning to more complex polymer materials to meet these demands. These materials need to be examined for their impact on human health and the environment; some polymers can release harmful substances when treated in certain ways.
Polypropylene (PP) films were prepared with a series of additives, and were then treated with electron beam irradiation and microwaves. The PP extracts were separated into six fractions by normal phase HPLC, followed by complete and automated on-line transfer of these to GC (comprehensive two-dimensional analysis, HPLC×GC).
The potential toxicity of the extracts was assessed using three in vitro short-term bioassays and their migrations were performed using a standards-based approach. After the electron-beam treatment some additives decomposed and there was a significant increase in the polyolefin oligomeric saturated hydrocarbons concentration. The electron-beam treatment had a stronger impact on the polymer than the microwave one. It produced degradation products from the additives as well as from the polymer. The additives reduced this degradation of the PP backbone significantly, but also formed degradation products themselves. The microwave treatments (800 or 1100 W) did not lead to structural changes in the PP film. However, the GC–FID–MS analysis indicated the presence of novel degradation products in the film (Irgafos 168 and Irganox 1076).
The team believes that this approach is a big step towards the assessment of the health risks of materials and objects in contact with food. It could also help to comply with the regulations concerning those materials that come into contact with food. - K.M.
Reference
Determining Neurotransmitters in Spinal Cords with UHPLC
February 18th 2025Researchers at Jilin University (Changchun, China) developed a highly sensitive, rapid, and accurate method for analyzing neurotransmitters (NTs) in rat spinal cord tissue. Ultra-high performance liquid chromatography-triple quadrupole tandem mass spectrometry (UHPLC-QqQ-MS/MS) in conjunction with ultra-ionic liquid dispersive liquid-liquid microextraction (UA-MIL-DLLME) were used to extract NTs for analysis.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
Revolutionizing LC-MS with Next-Gen Separation for Cyclic Peptide Analysis
February 17th 2025Cyclic peptides, known for their stability and high specificity, are promising therapeutic agents in the fight against cancer, infections, and autoimmune diseases. However, developing effective cyclic peptides presents numerous challenges, including poor pharmacokinetics, efficacy, and toxicity. Traditional methods like liquid chromatography tandem-mass spectrometry (LC-MS/MS) often struggle with resolving isomeric linear peptide metabolites, posing significant risks in safety, efficacy, and regulatory approval. In this paper, Komal Kedia, PhD, will share how she leveraged MOBIE’s high-resolution ion mobility-mass spectrometry (IM-MS) system to achieve a 72% reduction in run times, 200% greater resolving power, and enhanced accuracy in identifying “soft spots” prone to enzymatic degradation.